The present invention provides compounds of formula I ##STR1##

and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.

 
Web www.patentalert.com

< System and methods for soft tissue reconstruction

< Substituted 2-azetidinones useful as hypocholesterolemic agents

> Heteroaryl urea neuropeptide Y Y5 receptor antagonists

> Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists

~ 00230